Aclaris Therapeutics (ACRS) Accused of Making Misleading Claims Regarding its ESKATA Drug According to the complaint against the company’s officers and directors for breaches of fiduciary duties, unjust enrichment, abuse

Aurora Cannabis Inc. (ACB) Accused of Misleading Shareholders  According to the complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between September 11, 2019 and

Overstock.com, Inc. (OSTK) Accused of Misleading Shareholders  According to the complaint for alleged violations of the Securities Exchange Act of 1934 between May 9, 2019 and November 11, 2019, Overstock,

Energy Transfer LP (ET) Accused of Bribery  According to the complaint for violations of the Securities Exchange Act of 1934, in February 2017, the Pennsylvania Department of Environmental Protection approved

Robbins LLP is Investigating the Officers and Directors of Sage Therapeutics, Inc. (SAGE) on behalf of Shareholders We are investigating whether certain officers and directors of Sage Therapeutics, Inc. breached

Canopy Growth Corp.’s (CGC) Accused of Misleading Shareholders According to the complaint for securities violations, in June 2019, Canopy filed its Form 6-K with the SEC, touting fourth quarter 2019

Henry Schein, Inc. (HSIC) Accused of Antitrust and Securities Violations    According to the complaint against the Company’s officers and directors for breaches of fiduciary duties, unjust enrichment, abuse of

GrubHub, Inc. (GRUB) Accused of Misleading Investors According to the complaint for alleged violations of the Securities Exchange Act of 1934 between July 30, 2019 and October 28, 2019, in